TMDX vs. NVO
Compare and contrast key facts about TransMedics Group, Inc. (TMDX) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TMDX or NVO.
Correlation
The correlation between TMDX and NVO is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
TMDX vs. NVO - Performance Comparison
Key characteristics
TMDX:
-0.03
NVO:
-1.18
TMDX:
0.46
NVO:
-1.72
TMDX:
1.06
NVO:
0.77
TMDX:
-0.03
NVO:
-0.86
TMDX:
-0.06
NVO:
-1.74
TMDX:
39.77%
NVO:
26.39%
TMDX:
70.82%
NVO:
38.77%
TMDX:
-73.69%
NVO:
-71.29%
TMDX:
-59.71%
NVO:
-53.42%
Fundamentals
TMDX:
$2.39B
NVO:
$296.36B
TMDX:
$1.07
NVO:
$3.27
TMDX:
66.32
NVO:
20.52
TMDX:
$344.69M
NVO:
$225.05B
TMDX:
$202.02M
NVO:
$190.45B
TMDX:
$46.39M
NVO:
$113.24B
Returns By Period
In the year-to-date period, TMDX achieves a 13.81% return, which is significantly higher than NVO's -20.74% return.
TMDX
13.81%
2.68%
-50.65%
-5.83%
43.13%
N/A
NVO
-20.74%
-22.08%
-40.75%
-46.11%
19.54%
11.49%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TMDX vs. NVO — Risk-Adjusted Performance Rank
TMDX
NVO
TMDX vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for TransMedics Group, Inc. (TMDX) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
TMDX vs. NVO - Dividend Comparison
TMDX has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 2.40%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TMDX TransMedics Group, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 2.40% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
Drawdowns
TMDX vs. NVO - Drawdown Comparison
The maximum TMDX drawdown since its inception was -73.69%, roughly equal to the maximum NVO drawdown of -71.29%. Use the drawdown chart below to compare losses from any high point for TMDX and NVO. For additional features, visit the drawdowns tool.
Volatility
TMDX vs. NVO - Volatility Comparison
TransMedics Group, Inc. (TMDX) has a higher volatility of 13.88% compared to Novo Nordisk A/S (NVO) at 12.78%. This indicates that TMDX's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
TMDX vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between TransMedics Group, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities